Search research articles
Contact Us
Filters
Showing results (31-40 of 148) with videos related to
Page
of 15
Sort By:
American Journal of Hematology
|
January 10, 2023
A phase II study of combination daunorubicin, cytarabine (Ara-c), and nilotinib (TAsigna) (DATA) in patients newly diagnosed with acute myeloid leukemia with KIT expression
Aref Al-Kali, Raoul Tibes, Pamela Atherton, et al.
Haematologica
|
November 8, 2011
Hypocellular acute myeloid leukemia in adults: analysis of the clinical outcome of 123 patients
Aref Al-Kali, Sergej Konoplev, Erpei Lin, et al.
Oncotarget
|
May 5, 2016
Liposomal bortezomib is active against chronic myeloid leukemia by disrupting the Sp1-BCR/ABL axis
Xiaojuan Yang, Jiuxia Pang, Na Shen, et al.
Clinical Colorectal Cancer
|
September 17, 2008
Aggressive combined modality therapy for recurrent colorectal cancer involving the duodenum and pancreas: a report of 5 cases
Michael J Overman, David Fogelman, Aref Al-Kali, et al.
Haematologica
|
March 20, 2025
Predictors of response to pacritinib therapy and survival among 60 Mayo Clinic patients with myelofibrosis treated outside of clinical trials
Maymona Abdelmagid, Jeanne M Palmer, Aref Al-Kali, et al.
International Journal of Cancer
|
October 13, 2015
Tyrosine kinase inhibitors as a first-line treatment in patients with newly diagnosed chronic myeloid leukemia in chronic phase: A mixed-treatment comparison
Belal Firwana, Mohamad Bassam Sonbol, Maria Diab, et al.
British Journal of Haematology
|
November 3, 2021
Cladribine therapy for advanced and indolent systemic mastocytosis: Mayo Clinic experience in 42 consecutive cases
Ayalew Tefferi, Jaya Kittur, Faiqa Farrukh, et al.
American Journal of Hematology
|
September 29, 2023
Granularity in disease classification impacts survival prediction in advanced systemic mastocytosis: A single institution study of 329 informative cases
Ayalew Tefferi, Maymona Abdelmagid, Aref Al-Kali, et al.
Cancer
|
April 12, 2023
Phase 1/1b study of azacitidine and hedgehog pathway inhibitor sonidegib in patients with myeloid neoplasms
Raoul Tibes, Heidi E Kosiorek, Amylou C Dueck, et al.
American Journal of Hematology
|
October 13, 2017
Therapy related-chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from de novo CMML
Mrinal M Patnaik, Rangit Vallapureddy, Fevzi F Yalniz, et al.
Page
of 15
Search research articles
Search
Showing results (31-40 of 148) with videos related to
Sort By:
Page
of 15
American Journal of Hematology
|
January 10, 2023
A phase II study of combination daunorubicin, cytarabine (Ara-c), and nilotinib (TAsigna) (DATA) in patients newly diagnosed with acute myeloid leukemia with KIT expression
Aref Al-Kali, Raoul Tibes, Pamela Atherton, et al.
Haematologica
|
November 8, 2011
Hypocellular acute myeloid leukemia in adults: analysis of the clinical outcome of 123 patients
Aref Al-Kali, Sergej Konoplev, Erpei Lin, et al.
Oncotarget
|
May 5, 2016
Liposomal bortezomib is active against chronic myeloid leukemia by disrupting the Sp1-BCR/ABL axis
Xiaojuan Yang, Jiuxia Pang, Na Shen, et al.
Clinical Colorectal Cancer
|
September 17, 2008
Aggressive combined modality therapy for recurrent colorectal cancer involving the duodenum and pancreas: a report of 5 cases
Michael J Overman, David Fogelman, Aref Al-Kali, et al.
Haematologica
|
March 20, 2025
Predictors of response to pacritinib therapy and survival among 60 Mayo Clinic patients with myelofibrosis treated outside of clinical trials
Maymona Abdelmagid, Jeanne M Palmer, Aref Al-Kali, et al.
International Journal of Cancer
|
October 13, 2015
Tyrosine kinase inhibitors as a first-line treatment in patients with newly diagnosed chronic myeloid leukemia in chronic phase: A mixed-treatment comparison
Belal Firwana, Mohamad Bassam Sonbol, Maria Diab, et al.
British Journal of Haematology
|
November 3, 2021
Cladribine therapy for advanced and indolent systemic mastocytosis: Mayo Clinic experience in 42 consecutive cases
Ayalew Tefferi, Jaya Kittur, Faiqa Farrukh, et al.
American Journal of Hematology
|
September 29, 2023
Granularity in disease classification impacts survival prediction in advanced systemic mastocytosis: A single institution study of 329 informative cases
Ayalew Tefferi, Maymona Abdelmagid, Aref Al-Kali, et al.
Cancer
|
April 12, 2023
Phase 1/1b study of azacitidine and hedgehog pathway inhibitor sonidegib in patients with myeloid neoplasms
Raoul Tibes, Heidi E Kosiorek, Amylou C Dueck, et al.
American Journal of Hematology
|
October 13, 2017
Therapy related-chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from de novo CMML
Mrinal M Patnaik, Rangit Vallapureddy, Fevzi F Yalniz, et al.
Page
of 15